mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.01 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.01 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.02 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |